A Local Drug Delivery System Based on Visible Light-Cured Glycol Chitosan and Doxorubicin Hydrochloride for Thyroid Cancer Treatment In Vitro and In Vivo

    January 2018 in “ Drug Delivery
    Young-Bum Yoo, Sun-Jung Yoon, So Yeon Kim, Deok‐Won Lee, Sewook Um, Hoon Hyun, Sung Ok Hong, Dae Hyeok Yang
    TLDR GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.
    The study developed a visible light-cured glycol chitosan hydrogel system loaded with doxorubicin⋅hydrochloride for thyroid cancer treatment, tested both in vitro and in vivo. The system showed controlled drug release, superior antitumor effects, and significant tumor volume reduction in mice, with minimal systemic toxicity. This suggested its potential for effective and safer localized chemotherapy for thyroid cancer.
    Discuss this study in the Community →